Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic rhTPO for chemotherapy-induced thrombocytopenia
ChiCTR-TRC-09000433Phase 4Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Aug 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of recombinant human thrombopoietin in Thrombocytopenia (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Platelet transfusion amount and rate. Started Aug 2007; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on ChiCTR-TRC-09000433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000433.